News and Announcements
Circular Energy Group announces formation of Advisory Board Committee composed of industry experts
- Published January 18, 2023 7:44AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Dear Investors,
Announcement: Advisory Board and on-board
We are excited to announce the formation of our Advisory Board Committee, composed of industry experts who will provide valuable insights and guidance to our Board of Directors. These accomplished individuals were carefully selected for their expertise in their respective fields and will play a key role in shaping the strategic direction of Circular Energy Group.
We are pleased to introduce our Advisory Board members:
- Jed Durdin, Rodd Beitmanas
- Noon McNamara
- Jeremy Goldman
- Ian Lieblich
- Corey Wingard
- Nick Lagonik
- and Amanda Rischbieth
They bring a wealth of experience in areas such as legal and corporate strategy, ESG, policy and government, clean alternative fuels, and climate health.
We look forward to the valuable contributions and robust discussions that our Advisory Board will bring to our decision-making process. Our first Advisory Board Committee meeting will take place on Tuesday, January 3, 2023, in Adelaide.
For further information, please contact Noon McNamara at [email protected].
Thank you for your continued support,
The Circular Energy Group Board of Directors
Connect with the company and learn more about Circular Energy Group by accessing their deal room here.
Company Updates
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts
As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.
Dying for a Cure: Why Astraea is Stress-Testing the Future of Space Medicine
Astraea Technologies is solving a critical “blind spot” in the $1.5T space economy. Co-founders Brooke Mills and Gordon Carroll discuss their $5M seed raise, the HIRO-LAB platform, and their upcoming 2028 mission to the Moon to validate life-saving medicine in extreme environments.
Beyond the Drip: Elemental IV’s Infrastructure Play for a Fragile Supply Chain
In the high-stakes world of life sciences, we often hunt for the next “miracle molecule” or gene-editing breakthrough. But Storme Paes, Founder and Commercial Director of Elemental IV, found her mission in something far more fundamental, yet dangerously overlooked: a simple bag of saltwater. The “Meeting Room” Revelation The genesis of Elemental IV didn’t occur […]
Backed By Leading Investment Groups and Family Offices
